A study by Guo et al. further demonstrated that CVB3-induced DCM was protected by IL-22-producing Th22 cells, illustrating that splenic Th22 cell numbers, plasma IL-22 levels, and myocardial IL-22 R expression were all elevated in the mice with DCM. The gene discussed is IL22; the disease is familial dilated cardiomyopathy.